Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1971 Aug;4(2):143–148. doi: 10.1128/iai.4.2.143-148.1971

In Vitro Antifungal Activity of Clotrimazole (Bay b 5097)

Smith Shadomy 1
PMCID: PMC416278  PMID: 4949484

Abstract

The in vitro antifungal activity of clotrimazole (Bay b 5097) was compared with those of amphotericin B, griseofulvin, nystatin, and pyrrolnitrin. The inhibitory activity of clotrimazole against most systemic pathogens was comparable to that of amphotericin B; minimal inhibitory concentrations of the two drugs for Blastomyces dermatitidis, Histoplasma capsulatum, Sporothrix schenckii, Cryptococcus neoformans, and Coccidioides immitis were in the range of 0.20 to 3.13 and 0.10 to 6.25 μg/ml, respectively. One isolate of Allescheria boydii was resistant to 100 μg of amphotericin B per ml but was inhibited by 6.25 μg of clotrimazole per ml. Clotrimazole was less active than amphotericin B against Candida albicans and Aspergillus fumigatus. The activity of clotrimazole against dermatophytes was comparable to that of pyrrolnitrin; 0.78 μg of either compound per ml was fungicidal for most isolates of Trichophyton sp., Microsporum sp. and Epidermophyton floccosum. Both griseofulvin and nystatin were less active than clotrimazole. The size of inoculum was shown to have a significant effect on the results of in vitro susceptibility testing with clotrimazole.

Full text

PDF
143

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Marget W., Adam D. Erste Erfahrungen mit dem Breitbandantimykotikum BAY b 5097. Med Klin. 1969 Jul 4;64(27):1235–1238. [PubMed] [Google Scholar]
  2. Oberste-Lehn H., Baggesen I., Plempel M. Erste klinische Erfahrungen bei System-Mykosen mit einem neuen oralen Antimykotikum. Dtsch Med Wochenschr. 1969 Jun 27;94(26):1365–passim. doi: 10.1055/s-0028-1111224. [DOI] [PubMed] [Google Scholar]
  3. Plempel M., Bartmann K., Büchel K. H., Regel E. BAY b 5097, a new orally applicable antifungal substance with broad-spectrum activity. Antimicrob Agents Chemother (Bethesda) 1969;9:271–274. [PubMed] [Google Scholar]
  4. Plempel M., Bartmann K., Büchel K. H., Regel E. Experimentelle Befunde über ein neues, oral wirksames Antimykotikum mit breiten Wirkungsspektrum. Dtsch Med Wochenschr. 1969 Jun 27;94(26):1356–passim. doi: 10.1055/s-0028-1111223. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES